Literature DB >> 8399082

Underexpression of the apolipoprotein E4 isoform in an Italian population.

R W James1, M Boemi, R Giansanti, P Fumelli, D Pometta.   

Abstract

Apolipoprotein (apo) E polymorphism was examined in a population of Italian blood donors. A significantly reduced frequency of the epsilon 4 allele was observed in comparison to a combined Caucasian population. Apo E polymorphism was also associated with significant differences in plasma lipid and lipoprotein levels. Notably, total and low-density lipoprotein cholesterol as well as triglycerides were increased, whereas high-density lipoprotein cholesterol was decreased in carriers of the E4 isoform. This is the first report of a significantly lower frequency of the apo E4 isoform in a European population. The reduced occurrence of an apo E isoform, which is associated with a more atherogenic lipid/lipoprotein profile, may be a contributory factor to the relatively lower incidence of cardiovascular disease in the Italian population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399082     DOI: 10.1161/01.atv.13.10.1456

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  3 in total

Review 1.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

2.  Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey.

Authors:  Sevki Cetinkalp; Muammer Karadeniz; Mehmet Erdogan; Ayhan Zengi; Vildan Cetintas; Asli Tetik; Zuhal Eroglu; Buket Kosova; A Gokhan Ozgen; Fusun Saygili; Candeger Yilmaz
Journal:  J Assist Reprod Genet       Date:  2008-12-05       Impact factor: 3.412

3.  ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size.

Authors:  C M Barbagallo; F Polizzi; M Severino; M Rizzo; N Vivona; F Onorato; R Caldarella; A B Cefalù; D Noto; A Notarbartolo; M R Averna
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.